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The rapid, accurate, and efficient identification of an infectious disease is critical to 
ensure timely clinical treatment and prevention in public health settings. In 2015, men-
ingitis caused by Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria 
meningitidis was responsible for 379,200 (range: 322,700–444,700) deaths. Clinical 
features alone cannot determine whether bacterial meningitis is present; an analysis of 
cerebrospinal fluid (CSF) is essential. Loop-mediated isothermal amplification (LAMP) is 
a nucleic acid amplification method offering an alternative to polymerase chain reaction 
(PCR). LAMP-based assays for detection of three leading bacteria in CSF for diagnosis 
of meningitis have been established. The typing assays using LAMP for detection of 
meningococcal serogroups A, B, C, W, X, and Y as well as H. influenzae serotypes 
a, b, c, d, e, and f were launched. In comparative analysis of the meningitis patho-
gen assays, LAMP assays did not yield false negative results, and the detection rate 
of LAMP assays was superior compared with PCR or conventional culture methods. 
LAMP assays provide accurate and rapid test results to detect major bacterial meningitis 
pathogens. Accumulating evidence suggests that LAMP assays have the potential to 
provide urgently needed diagnostics for bacterial meningitis in resource-limited settings 
of both developed and developing countries.
Keywords: loop-mediated isothermal amplification, meningitis, cerebrospinal fluid, Neisseria meningitidis, 
Haemophilus influenzae, Streptococcus pneumoniae, serotype identification
inTRODUCTiOn
Over the past several decades, the incidence of meningitis caused by Streptococcus pneumoniae and 
Haemophilus influenzae in children has declined due to widespread vaccination (1, 2). Recent suc-
cess in the introduction of the meningococcal conjugate serogroup A vaccine has underscored the 
importance of continued clinical and epidemiologic surveillance for invasive meningococcal disease 
across countries where the vaccine has been deployed (3). At the same time, the incidence of invasive 
diseases due to bacterial strains that were not included in the vaccines has increased (2, 4, 5). Even 
with appropriate antimicrobial therapy, the burden of disease in adults and mortality both in adults 
and children remain high in several countries, particularly resource-limited countries (6).
2
Seki et al. LAMP Assays for Bacterial Meningitis
Frontiers in Pediatrics | www.frontiersin.org March 2018 | Volume 6 | Article 57
Polymerase chain reaction (PCR)-based assays are relatively 
expensive and complex to perform in resource-limited laboratory 
settings. Loop-mediated isothermal amplification (LAMP) is a 
nucleic acid amplification method offering the rapid, accurate, 
and easy to use diagnosis of infectious diseases (7, 8). LAMP-
based diagnostic assays for S. pneumoniae, H. influenzae, and 
N. meningitidis have been established (9–13). The typing assays 
using LAMP for the detection of N. meningitidis serogroups 
[A, B, C, W, X, and Y (14)] and H. influenzae serotypes [a, b, c, d, 
e, and f (15)] were released.
In 2015, meningitis caused by S. pneumoniae, H. influen­
zae, and N. meningitidis was responsible for 379,200 (range: 
322,700–444,700) deaths (16). Clinically, the rapid, accurate, 
and efficient identification of an infectious agent is critical to 
ensure prompt, safe and effective therapy. Yet, clinical features 
alone cannot determine whether bacterial meningitis is present; 
an analysis of cerebrospinal fluid (CSF) is essential for diagnosis. 
Bacterial culture methods require a well-equipped laboratory 
with appropriate biosafety facilities, specialized bacterial culture 
media, and reagents. In developing countries, the accurate 
diagnosis of bacterial meningitis remains a challenge due to the 
limited availability of routine microbiology laboratory services 
(17). Moreover, because early empiric treatment with antibiotics 
is commonplace in many countries, bacterial growth in standard 
culture media may be inhibited by the antibiotics present in 
human clinical samples.
For decades, the lack of available diagnostic tests in developing 
countries has been associated with widespread empiric antibiotic 
treatment and rising antibiotic resistance. There is urgent need 
to develop and deploy effective diagnostic tests that meet the 
criteria needed to ensure global access to end-users in developed 
and developing countries. Despite technological innovations, 
low-cost, sensitive and specific diagnostic tests for major bacte-
rial pathogens remain unavailable in many resource-limited 
countries. The goal of this report is to review rationale, strategy, 
and opportunities for application of LAMP diagnostic methods 
for bacterial meningitis.
LAMP SPeCiFiCiTY
The isolation and identification of pneumococcus are com-
plicated by contamination with alpha-hemolytic streptococci 
(Streptococcus mitis and Streptococcus oralis) belonging to the 
normal flora. S. mitis and S. oralis are most closely related to 
pneumococcus on this ecological basis, and their 16S rRNA 
sequences share over 99% identity with those of pneumococ-
cus, making it difficult for clinical laboratories to differentiate 
pneumococcus from other oral alpha-hemolytic strepto-
cocci (18). Such misidentification might affect diagnosis and 
treatment.
The development of PCR-based assays targeting the ply (19) 
and lytA (20) genes was an important milestone in the labora-
tory diagnosis of pneumococcus. However, ply and lytA, initially 
thought to be present only in S. pneumoniae, were reported in 
strains of S. mitis (18). PCR-based tests that target these genes 
might result in the over-detection of pneumococcus. In many 
cases, PCR or real-time PCR methods are still not appropriate 
for resource-limited settings due to their technical requirements 
and cost.
The detection of S. pneumoniae teichoic acid antigen in 
urine (Binax NOW® S. pneumoniae; Alere International Ltd., 
Galway, Ireland) is an alternative to culture or PCR; however, its 
specificity is low in children because of false-positive results in 
healthy children carrying pneumococci and other closely related 
Streptococcus species (21).
The matrix-assisted laser desorption ionization–time of flight 
mass spectrometry (MALDI-TOF MS) technique has emerged 
as a clinical microbiology laboratories for the identification of a 
wide range of pathogens, however, the specificity of MALDI-TOF 
test for the differentiation of pneumococci from other mitis group 
streptococci is still low and often recognized false-positives (22). 
Moreover, its apparatus is too expensive and complex to use in 
developing countries.
The LAMP assay has high specificity because the LAMP 
reaction occurs only when all six to eight regions within a target 
DNA are recognized correctly by the primers (8). Thus, the 
higher analytical specificity of the LAMP assay compared to other 
methods, including PCR, has been recognized in the published 
literature (9, 11, 23). Using 25 clinically isolated streptococcal 
strains, a LAMP test targeting lytA succeeded in differentiating 
4 S. pneumoniae strains from 21 other Streptococcus species 
(3 S. oralis, 17 S. mitis, and 1 Streptococcus species) known to carry 
ply and, lytA whereas PCR produced 4 false-positive results for 
lytA and 17 false-positive results for ply (11, 23).
To assess H. influenzae type b (Hib) carriage, laboratory 
facilities for the reliable cultivation of Hib and identification of 
the capsular polysaccharide by immunological techniques are 
necessary. However, capsular antigen serotyping may produce 
inconsistent results; for example, 68% of isolates identified as 
Hib by serotyping yielded false-positives by PCR (24). Thus, in 
developing countries, the accurate diagnosis of Hib remains a 
challenge. A LAMP primer set for detecting Hib has been estab-
lished and was compared with conventional PCR for the detec-
tion of bexA (25) and nested PCR for the detection of six capsule 
types of Hib (26). Using 46 H. influenzae strains and 21 non- 
H. influenzae strains, both of the nested PCR and LAMP assays 
for Hib accurately discriminated standard reference Hib strains 
from non-Hib strains, whereas the slide agglutination serotyping 
test yielded one false-positive and two false-negative results (9).
The identification and serogrouping of N. meningitidis infec-
tion are important for disease control and vaccination strategies. 
However, N. meningitidis is still diagnosed using classical culture 
methods. Neisseria meningitidis is subdivided into 13 serogroups 
based on the capsular polysaccharide type (A, B, C, D, E, H, I, K, 
L, W, X, Y, and Z); however, most invasive meningococcal disease 
has been attributed to six serogroups (A, B, C, W, X, and Y) (27). 
Five of these serogroups (A, B, C, W, and Y) are targets in cur-
rently licensed meningococcal vaccines.
A rapid diagnostic test using an immunochromatographic 
method for the identification of N. meningitidis serogroups A, 
C, W, and Y utilizing monoclonal antibodies against the polysac-
charides of these four serogroups has been developed and used 
in endemic regions of Africa (28). Several PCR-based methods 
for the diagnosis of N. meningitidis infection and serogrouping 
TABLe 1 | Limits of bacterial DNA detection in LAMP and PCR assays for 
meningitis pathogens using spiked CSF specimens.




PCR LAMP PCR LAMP
S. pneumoniae/lytA (11) 104 copies/
reaction
10 104 10
Hib/capsulation locus region II (9) 103 10 103 10
N. meningitidis/ctrA (12) 104 10 105 10
N. meningitidis/ctrA (10) 10a 6 NA NA
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of the six major serogroups have been developed (29, 30). Using 
the LAMP technique, N. meningitidis detection (12) and specific 
identification of the six major serogroups (A, B, C, W, X, and Y) of 
N. meningitidis (14) have been established, and their specificities 
have been confirmed.
LAMP SenSiTiviTY
Loop-mediated isothermal amplification employs a DNA poly-
merase with strand-displacement activity, along with two inner 
primers (forward and backward inner primers) and two outer 
primers (F3 and B3) that recognize six separate regions within 
a target DNA sequence. This method utilizes a unique priming 
mechanism that yields specific DNA products in less time than 
PCR. Additional primers (i.e., loop primers: loop primer for-
ward and loop primer backward) designed to anneal to the loop 
structure in LAMP can be used to accelerate the LAMP reaction, 
resulting in enhanced sensitivity, and loop primers are now com-
monly used in practical applications of LAMP (8).
Table  1 shows detection limits of LAMP and PCR assays 
detecting DNA of meningitis pathogens and using spiked CSF 
specimens. The pneumococcus LAMP method could detect as 
few as 10 copies of both purified DNA and spiked CSF specimens 
within 30  min with greater sensitivity than conventional PCR 
(11). The sensitivity of the LAMP method was comparable to that 
of real-time PCR targeting lytA (31). Hib LAMP also detects 10 
copies of purified DNA in a 60-min reaction, reflecting a detec-
tion limit with a more than 100-fold greater sensitivity than both 
PCR for the detection of bexA and nested PCR for the detection 
of Hib (9). The meningococcus LAMP assay was more sensitive 
than the previously described PCR method. The detection limit 
of the LAMP assay was measured down to around 10 copies per 
reaction with a greater sensitivity than that of conventional PCR 
(10, 12). Using the DNA spike CSF specimens as a template, the 
detection limit of meningococcal PCR detection method was 
attenuated while that of LAMP method unchanged.
To obtain sensitive reaction results from conventional PCR 
assays, a DNA extraction and purification step is required because 
biological fluids and substances contained in clinical samples 
inhibit reactions (32–34). This additional step makes it difficult 
to perform PCR as part of a bedside examination because the 
DNA extraction is a somewhat troublesome procedure requiring 
more than 30 min to complete as well as specific equipment and 
the added expense of a DNA extraction kit. LAMP exhibits less 
sensitivity to inhibitory substances such as serum, plasma, urine, 
and culture medium present in biological samples than PCR (35). 
In fact, the robustness of LAMP in the face of reaction inhibitors 
can contribute to saving the time and cost required for sample 
processing steps.
LAMP ASSAY evALUATiOn USinG 
CLiniCAL CSF SPeCiMenS
The suitability of LAMP methods for detecting bacterial men-
ingitis in CSF was validated with up to 1,574 randomly selected 
CSF samples from children with suspected meningitis in Korea, 
China, and Vietnam collected between 1999 and 2002 in pro-
spective studies of bacterial meningitis (36–38). For comparison, 
CSF specimens were also tested by conventional PCR and culture 
tests. The comparative analysis of the meningitis pathogen LAMP 
assays, the clinical sensitivity, specificity, positive predictive value, 
and negative predictive value of the LAMP assays were compared 
with the PCR or conventional culture methods (9, 11, 12).
The pneumococcus detection rates of the LAMP, PCR and 
culture methods from CSF were 31.1% (33/106), 17.0% (18/106), 
and 10.4% (11/106), respectively. The detection rates for Hib were 
57.7% (30/52), 42.3% (22/52), and 40.4% (21/52), respectively. 
Those of meningococcus were 2.0% (31/1,574), 1.6% (25/1,574), 
and 0.2% (3/1,574), respectively. The detection rates of the LAMP 
method were substantially higher than those of PCR and culture 
tests, even though the method for extraction of DNA was only 
heating at 95°C for 2 min.
Table 2 lists the overall performances of the LAMP and PCR 
assays used to detect three meningitis bacteria. The sensitivity, 
specificity, and positive and negative predictive values for the 
pneumococcus LAMP assay were 100.0% (18/18), 83.0% (73/88), 
54.5% (18/33), and 100.0% (73/73), respectively, relative to PCR 
for diagnosis of pneumococcus infection. The comparable values 
of the Hib LAMP assay were 100.0% (22/22), 73.3% (22/30), 73.3% 
(22/30), and 100.0% (22/22), respectively. Those of the meningo-
coccus LAMP assay were 100.0% (25/25), 99.6% (1,543/1,549), 
80.6% (25/31), and 100.0% (1,543/1,543), respectively.
It seems that in clinical CSF specimens, these LAMP methods 
have almost perfect clinical sensitivity and negative predictive 
value with high clinical specificity and positive predictive value 
for the detection of the targeted bacterial meningitis pathogens. 
Moreover, the DNA extraction from CSF specimens can be easily 
achieved by heating to 95°C for 2 min.
In the United Kingdom, a bedside meningococcal LAMP test 
was determined to have a positive predictive value of 100% and 
a negative predictive value of 97%, while their samples included 
blood or combined nasal and throat swabs (39).
PeRSPeCTiveS
Loop-mediated isothermal amplification methods for serogroup-
ing meningococcus and serotyping Haemophilus influenzae 
TABLe 2 | A comparative analysis of PCR and LAMP for detection of bacterial meningitis.
Bacteria/primer target Method 
for DnA 
extraction




SS (%) SP (%) PPv (%) nPv (%)
S. pneumoniae/lytA (11) 95°C, 2 min China, Korea, 
Vietnam








Hib/capsulation locus region 
II (9)








N. meningitidis/ctrA (12) China, Korea, 
Vietnam








SS, sensitivity; SP, specificity; PPV, positive predictive value; NPV, negative predictive value.
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have been established (9, 14, 15). However, LAMP methods for 
pneumococcus serotyping have not yet been available, and some 
studies have reported the incidence of invasive diseases due to 
pneumococcal strains that were not included in the vaccines 
(2, 40, 41). Pneumococcus has a highly diverse polysaccharide 
capsule, containing more than 90 different serotypes. The dis-
tribution of those serotypes varies geographically (42, 43). The 
available pneumococcal conjugate vaccines were designed to 
provide immunity against the most prevalent invasive serotypes 
worldwide (42). Understanding the geographic distribution and 
shifts in prevalence over time of every serotype is important for 
optimizing vaccine design and assessing the postvaccine intro-
duction impact on disease burden. For the diagnosis of pneumo-
coccal serotypes, LAMP tests that can generate multiple results 
simultaneously (multiplex format) would be advantageous.
Loop-mediated isothermal amplification reactions require 
separate reaction tubes for each pathogen or each target gene 
because test positivity is confirmed by the observation of tur-
bidity in each reaction tube. The μTAS (micro Total Analysis 
Systems) or Lab on a Chip are next-generation LAMP detection 
devices (44) that enable the detection of multiple LAMP results 
simultaneously in a single microplate. Such a development has 
already started (45).
Because of the robustness and one-step reaction features of 
the LAMP assay (46), it could be easily applied to such next-
generation reaction devices. In this case, a dried formulation of 
LAMP reagents (44) or a simple visual detection technique (7, 47) 
should be useful in developing LAMP tests capable of generat-
ing multiple results simultaneously. A multiple-LAMP assay for 
the diagnosis of bacterial meningitis could be applied to clinics 
in resource-limited settings. In this case, prospective studies of 
the LAMP assay should be done using clinical specimens and 
compare with conventional bacterial culture, antigen detection, 
PCR, etc.
CLiniCAL APPLiCATiOn
Clinical diagnosis of acute and potentially fatal infectious diseases 
remains a major priority in developed and developing countries. 
While a host of new and relatively expensive diagnostic platforms 
are in clinical use and development, there remains a need for lower 
cost meningitis diagnostic tests that can be performed by labora-
tory technicians with limited training and time. As hospitals seek 
to contain rising healthcare costs, LAMP assays for meningitis 
offer rapid, accurate, and easy to use detection of bacterial DNA 
that can be completed in a short time compared with bacterial 
culture. LAMP assays for the diagnosis of meningitis also fulfill 
other key requirements of tests to detect dangerous pathogens 
including the ability to be completed safely in standard clinical 
laboratory facilities present in the majority of tertiary care and 
community hospitals around the world.
Presently, several manufacturers have successfully launched 
validated LAMP-based diagnostic tests (44). In all cases, the 
diagnostic test manufacturers have licensed the LAMP technol-
ogy with royalties going to patent holders in Japan. In coming 
years (the end of 2018), the primary LAMP technology patent 
is expected to expire. When this occurs, LAMP technology may 
be accessible in a broad range of healthcare environments across 
several regions worldwide. Expanding LAMP technology access 
across low- and middle-income countries may also be vital to 
improving diagnostic capacity, supporting prudent antibiotic 
usage and combating antimicrobial resistance. Deployment of 
LAMP assays offers the potential to provide urgently needed 
diagnostics for bacterial meningitis in resource-limited countries 
where there is a need for accurate case diagnosis to guide therapy 
on the frontline of patient care.
PUBLiC HeALTH PeRSPeCTiveS
The rapidly evolving field of diagnostic testing has improved the 
availability of rapid diagnostic point-of-care (POC) tests that 
include assays that can be widely distributed and require a limited 
amount of training by end-users. For example, antigen detection 
POC tests that use urine specimens for testing have improved 
the detection of bacterial infections caused by S. pneumoniae—
particularly in institutions where microbiologic culture methods 
may not be available (48). As molecular POC diagnostics such 
as LAMP assays become more widely available, their usage has 
the potential to improve public health surveillance and outbreak 
detection. Ultimately, the use of such tests can encourage more 
judicious use of antibiotics (with the potential for helping to 
reduce antimicrobial resistance) and improve control of diseases 
that threaten populations in developing and developed coun-
tries. Future research will be needed to identify how and where 
countries can best deploy LAMP POC tests in health systems to 
maximize their benefit to public health.
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